Louis J Rubenstein Md is categorized under Internal Medicine Practitioners in Wakefield, RI and active since 1998.
Louis J Rubenstein Md was established in 1998, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Louis J Rubenstein at the company’s single location by writing to 481 Kingstown Road, Wakefield, Rhode Island RI 02879 or by phoning (401) 789-0283. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Louis J Rubenstein Md |
| Contact Person: | Louis J Rubenstein |
| Address: | 481 Kingstown Road, Wakefield, Rhode Island 02879 |
| Phone Number: | (401) 789-0283 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 1998 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Louis J Rubenstein Md was started in 1998 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Louis J Rubenstein for inquiries that concern Louis J Rubenstein Md by calling the company number (401) 789-0283, as your correspondence is most welcome. Additionally, the physical location of the single location of Louis J Rubenstein Md can be found at the coordinates 41.436804,-71.484753 as well as the street address 481 Kingstown Road in Wakefield, Rhode Island 02879.
For its online presence, you may visit Louis J Rubenstein Md’s website at and engage with its social media outlets through on Twitter and on Facebook.